A groundbreaking medication capable of preventing type 2 diabetes by up to 85% is offering new hope to those at risk, a ...

Semaglutide is revolutionizing kidney disease treatment for type 2 diabetes patients. Learn how it works and its potential ...

Researchers from Lund University, in collaboration with Newcastle University, have uncovered a potential breakthrough in ...

New research suggests that commonly used medications like antibiotics, antivirals, and anti-inflammatories could lower the ...

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that the U.S. Food and Drug Administration (FDA) has accepted ...

Lee Jones added that the new breakthrough designation brings ... MicroBiome Therapeutics has a lead product focused on diabetes treatment, while UK-based 4D Pharma is targeting irritable bowel ...

New Study Says It Can Dec. 20 ... Overactive Cells Linked to Type 2 Diabetes Dec. 18, 2024 — Researchers studied oxygen treatment as a potential therapy to target specific cells linked to ...

Diabetes affects over 37 million people in the United States, with most cases being type 2 diabetes. This condition, once ...

The FDA has approved Cobenfy, a new drug to treat people with schizophrenia that comes with fewer side effects.

The hospital previously conducted the first simultaneous kidney transplant using one robot for both donor and recipient.

GLP-1RA weight-loss drugs provide health benefits but also pose risks, including pancreatitis, kidney problems, and ...

Recent research from the (SDU) suggests that carrots may help regulate blood sugar levels and enhance gut health, offering ...